Editorial
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Respirol. Nov 28, 2015; 5(3): 180-187
Published online Nov 28, 2015. doi: 10.5320/wjr.v5.i3.180
Questions relating to premenstrual asthma
Antonio Pereira-Vega, José Luis Sánchez-Ramos
Antonio Pereira-Vega, Pneumology Service, Juan Ramón Jiménez Hospital, 21005 Huelva, Spain
José Luis Sánchez-Ramos, University of Huelva, 21071 Huelva, Spain
Author contributions: Pereira-Vega A and Sánchez-Ramos JL designed the study and wrote the manuscript.
Supported by The grants from Neumosur (7/2003) and the Health Ministry of the Regional Autonomous Government of Andalusia (0074/2005).
Conflict-of-interest statement: The authors report no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Antonio Pereira-Vega, MD, PhD, Pneumology Service, Juan Ramón Jiménez Hospital, Ronda Norte, s/n, 21005 Huelva, Spain. apv01h@gmail.com
Telephone: +34-9-59016240 Fax: +34-9-59016060
Received: July 3, 2015
Peer-review started: July 10, 2015
First decision: July 31, 2015
Revised: September 22, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: November 28, 2015
Core Tip

Core tip: Premenstrual asthma (PMA) refers to the exacerbation of asthma in women of fertile age during the premenstrual phase. Whether or not it is an asthma phenotype, its definition, etiopathogeny and treatment are issues still to be resolved. PMA seems to be a female asthma phenotype despite contradictory results. It can occur at any level of asthma severity and it is usually associated with poorer disease control. Its etiology is not well known, and there is no specific widely recognized treatment. We need new well-designed studies to compare asthmatic women with or without PMA, and good quality clinical trials.